We describe a simple iminunoturbidimetric method for quantifying lipoprotein(a) in serum based on latex-enhanced particle agglutination technology. Carboxylated latex particles (diameter 240 nm) covalently coated with F(ab')2 fragments of anti-lipoprotein(a) antibodies are incubated with the sample for 5 min at 37 °C, and the resulting agglutination is quantified by measuring the change of turbidity produced at 700 nm. The assay is rapid, precise and fully automated on the Hitachi 911 analyser. The assay range is about 0.03-0.9 g/1. Average analytical recovery was 97-8%. Precision (CV) ranged from 1.9 to 3.1% at different lipoprotein(a) values. There was no interference from bilirubin, Intfalipid®, haemoglobin, plasminogen or apolipoprotein B. Comparisons with a latex nephelometric assay carried out on the Behring nephelometer analyser, and with three commercially available methods, a radioimmunoassay and two ELISA assays, gave good correlations (r > 0.95), although a large among-method variation in lipoprotein(a) values was found. We conclude that the proposed latex turbidimetric immunoassay method is suitable for routine use in clinical laboratories.These findings generated the need for a serum lipoprotein(a) assay in the clinical chemistry laboratory. Various quantitative immunological assays for lipoprotein(a) determination, including electrophoretic techniques (10), radial immunodiffusion (11), enzyme immunoassays (12), and radio immunoassays (13) have been developed. However, these procedures generally require specialized reagents and equipment, long reaction times, and multiple washing steps, and they are not easily automated. Recently, in an effort to overcome these problems several automated fluid-phase immunoprecipitation procedures have been described (14,15).In this study, we present a turbidimetric method which uses particle-enhanced immunoassay technology and is carried out on a last generation clinical chemistry analyser. This turbidimetric method has the advantage of being precise, rapid, easy to perform, and suffers no interference from apolipoprotein B, plasminogen, or from endogenous lipids, haemoglobin, or bilirubin. Here we describe the characteristics and performance of the method.
AntibodyRabbit polyclonal antiserum directed against human lipoprotein(a) was manufactured by Dakopatts A/S (Glostrup, Denmark). It showed no cross-reaction with apolipoprotein B or plasminogen and was stored at 4°C. (Lot No. 012, 3.7 g/1 of protein.)Eur.